NASDAQ:PBAX Phoenix Biotech Acquisition (PBAX) Stock Price, News & Analysis → Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad) Free PBAX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$4.91▼$5.9550-Day Range$5.05▼$6.3352-Week Range$4.12▼$12.80Volume6,400 shsAverage Volume16,686 shsMarket Capitalization$36.56 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesOwnershipShort InterestSocial MediaStock AnalysisHeadlinesOwnershipShort InterestSocial Media Get Phoenix Biotech Acquisition alerts: Email Address Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report About Phoenix Biotech Acquisition Stock (NASDAQ:PBAX)Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. Phoenix Biotech Acquisition Corp. was incorporated in 2021 and is based in Oakland, California.Read More Ad Paradigm PressBiden replacement revealed?A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report PBAX Stock News HeadlinesFebruary 14, 2024 | businesswire.comPhoenix Biotech Acquisition Corp. and CERo Therapeutics, Inc. Announce Close of Business CombinationSee More Headlines Receive PBAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Phoenix Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorUnclassified Industry Holding & other investment offices Sub-IndustryN/A Current SymbolNASDAQ:PBAX CUSIPN/A CIK1870404 Webwww.phoenixbiotechacquisitioncorp.com Phone215-731-9450FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares6,250,000Free Float949,000Market Cap$36.56 million OptionableNot Optionable Beta0.05 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Christopher B. Ehrlich M.B.A. (Age 54)CEO & Director Dr. Douglas Carl Fisher M.B.A. (Age 48)M.D., President Mr. Daniel E. Geffken M.B.A. (Age 67)Chief Financial Officer Key CompetitorsPlutonian AcquisitionNASDAQ:PLTNQomolangma AcquisitionNASDAQ:QOMOWestern Acquisition VenturesNASDAQ:WAVSAult Disruptive TechnologiesNYSE:ADRTBroad Capital AcquisitionNASDAQ:BRACView All Competitors This page (NASDAQ:PBAX) was last updated on 5/24/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetryBiden replacement revealed?Paradigm PressGold Set to EXPLODE!Gold Safe ExchangeThis could mean the end of the U.S dollar…Colonial MetalsMost important medical advance in 100 yearsThe Oxford ClubTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phoenix Biotech Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.